|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cognitive behavioural therapy for auditory hallucinations in schizophrenia:A review显示文摘AIM To provide an updated of recent findings about efficacy of cognitive-behavior therapy(CBT) in reduction of command hallucinations.METHODS Pub Med/MEDLINE,Cochrane Library,the Cumulative Index to Nursing and Allied Health Literature,PsycI NFO,Clinical Trial.gov searches were performed using the keywords 'hallucinations','behavioural therapy' and ' cognitive therapy' in order to identify relevant articles published during the years of 2011 to 2016.No language limits were used.Studies conducted within control group,reviews,editorials,were excluded.Data on efficacy,acceptability and tolerability were extracted by three authors independently.Disagreements were resolved in a consensus meeting or by another reviewer.RESULTS A total of eight articles were eligible for inclusion.Two are randomized clinical trials(RCTs) and six are observational studies.The two RCTs included showed a greater efficacy of CBT compared to standard care on auditory hallucinations(AHs).Nevertheless,they considered different CBT models,particularly Treatment of Resistant Command Hallucinations and Cognitive Therapy for Command Hallucinations.As regards non RCT-studies,all papers included showed reduction on frequency and severity of AHs and distress related to them.However,the lack of content details within non-RCTs studies decreased their comparability.In terms of predictive variables,our findings show that negative symptoms at baseline appeared to be the strongest predictor of the treatment efficacy.Indeed,negative symptoms showed a significant negative correlation on outcome.CONCLUSION Although more conclusive studies are still needed,we found some preliminary evidence for the efficacy of CBT in the treatment of command hallucinations. | Maria Pontillo Franco De Crescenzo Stefano Vicari Maria Laura Pucciarini Roberto Averna Ornella Santonastaso Marco Armando | 2016 | World Journal of Psychiatry2016，6，3： | 4 |
| 2 | Gastrointestinal symptoms in infancy: A population-based prospective study显示文摘 | G. Iacono R. Merolla D. D’Amico E. Bonci F. Cavataio L. Di Prima C. Scalici L. Indinnimeo M.R. Averna A. Carroccio | 2005 | Digestive and Liver Disease2005，，6： | 2 |
| 3 | Hypertension and diabetes mellitus are associated with cardiovascular events in the elderly without cardiovascular disease. Results of a 15-year follow-up in a Mediterranean population显示文摘 | D. Noto A.B. Cefalù C.M. Barbagallo M. Sapienza G. Cavera I. Nardi M. Pagano N. Vivona A. Notarbartolo M.R. Averna | 2008 | Nutrition Metabolism and Cardiovascular Diseases2008，，5： | 1 |
| 4 | Thromboxane biosynthesis and platelet function in type 11 diabetes mellitus 显示文摘 | Davi G Catalano I Averna M | 1990 | N Engl J Med1990，322，25： | 1 |
| 5 | Changes in calpastatin localization and expression during calpain activation:A new mechanism for the regulation of intracellular Ca (2+)-dependent proteolysis 显示文摘 | Averna M R De Tullio | 2003 | Cell Mol Life Sci2003，60，： | 1 |
| 6 | Determinants of enhanced thromboxane biosynthesis in renal transplantation显示文摘 | Averna M Barbagallo CM Ganci A | 2001 | Kidney Int2001，59，4： | 1 |
| 7 | Thromboxane biosynthesis and platelet function in type Ⅱ diabetes mellitws显示文摘 | Davi G Catalano L Averna M | 1990 | N Engl J Med1990，322，： | 1 |
| 8 | Acyl - CoA - binding Protein Is a m - calpain Activator 显示文摘 | Melloni E Averna M Sa]amlno F Sparatore B and Minafra R | 2000 | The Journal of Biological Chemistry2000，，275： | 1 |
| 9 | Lipid-altering efficacy of ezetimibe/simv-astatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy-The IN-CROSS study显示文摘 | Farnier M Averna M Missault L | 2009 | International Journal of Clinical Practice2009，，04： | 1 |
| 10 | Lipoprotein(a) levels in the end-stage renal failure and renal transplantation显示文摘 | Barbagallo CM Averna MR Sparaelno V | 1993 | Nephron1993，64，4： | 1 |
| 11 | Lipoprotein (a) levels in end-stage renal failure and renal transplantation显示文摘 | Barbagallo CM Averna MR Sparacino V | | 0，，04： | 1 |
| 12 | Ener- gy cost of walking measurements in subjects with lower limb amputations: A comparison study between floor and treadmill test显示文摘 | TRABALLESI M PORCACCHIA P AVERNA T | 2008 | Gait Posture2008，27，1： | 1 |
| 13 | Inhibition of thromboxanebiosynthesis and platelet function by simvastatin in type IIahypercholesterolemia显示文摘 | Notarbartolo A Davi G Averna M | 1995 | Arterioscler Thromb Vasc Biol1995，15，2： | 1 |
| 14 | Genetic risk factors in myocardial infarction at young age显示文摘 | Incalcaterra E Hoffmann E Averna MR | 2004 | Minerva Cardioangiol2004，52，4： | 1 |
| 15 | Lipid-altering efifcacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy-The IN-CROSS study显示文摘 | Farnier M Averna M Missault L | | 0，，04： | 1 |
| 16 | A Novel APOB Mutation Identified by Exome Sequencing Cosegregates With Steatosis, Liver Cancer, and Hypocholesterolemia显示文摘 | Angelo B. Cefalù James P. Pirruccello Davide Noto Stacey Gabriel Vincenza Valenti Namrata Gupta Rossella Spina Patrizia Tarugi Sekar Kathiresan Maurizio R. Averna | 2013 | Arteriosclerosis Thrombosis and Vascular Biology2013，，8： | 1 |
| 17 | Acyl-CoA-binding protein is a potent m-calpain activator 显示文摘 | Melloni E Averna M Salamino F | 2000 | The Journal of Biological Chemistry2000，275，： | 1 |
| 18 | Lipid-altering efllcacy of switching to ezetimibe/simvastatin 10/20 mg versus resnvastatin 10 mg in high-risk patients with and without metabolic syndrome 显示文摘 | Averna M Missault L Vaverkova H | 2011 | Diab Vasc Dis Res2011，，4： | 1 |
| 19 | Potentiation of NMDA receptor-dependent cell responses by extracellular high mobility group box 1 protein显示文摘 | Pedrazzi M Averna M Sparatore B | 2012 | PLo S One2012，7，44： | 1 |
| 20 | Switching from statin monotherapy to ezetimibe/simvastatin or rosuvastatin modifies the relationships between apolipoprotein B, LDL cholesterol, and non- HDL cholesterol in patients at high risk of coronary disease显示文摘 | Vaverkova H Farnier M Averna M | 2011 | Clin Biochem2011，44，89： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员